Per the analyst data, the consensus is 11 Buy, 8 Hold, and 1 Sell, with 7 Strong Buy ratings and 0 Strong Sell. The mean price target is 97.95, the median is 97.6, the low target is 86.55, and the high target is 104.46. The implied upside is 17.01%, and the Street BS score is 61. Among the ten listed analyst actions, Barclays downgraded to UNDERPERFORM with a 86.55 target, while UBS reiterated OUTPERFORM with a 94.58 target and carries the lowest accuracy figure among the listed analysts at 53.8%. Morgan Stanley and Bank of America both upgraded to STRONG BUY in August and September 2026.
Per the holders data, recent 13F and congressional trades show buying: Duquesne Family Office bought 1,350,000 shares at 88.34 (total value 119,259,000), Citadel Advisors bought 1,180,000 shares at 93.15 (109,917,000), and Berkshire Hathaway bought 1,750,000 shares at 93.15 (163,012,500). Rep. Mark Green bought 3,800 shares at 83.65 (317,870) and Sen. Tommy Tuberville bought 3,100 shares at 85.84 (266,104). Insider Form 4 filings in the data are all SELL transactions: Nicole J. Daggs sold 4,934 shares at 93 (458,862), James Michael May sold 7,161 shares at 90.27 (646,423.47), and Mark Lemasney sold 3,845 shares at 90.27 (347,088.15), all filed in March 2026.